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Abstract
The COVID-19 pandemic has had a significant impact on many aspects of head
and neck cancer (HNC) care. The uncertainty and stress resulting from these
changes has led many patients and caregivers to turn to HNC advocacy groups
for guidance and support. Here we outline some of the issues being faced by
patients with HNC during the current crisis and provide examples of programs
being developed by advocacy groups to address them. We also highlight the
increased utilization of these organizations that has been observed as well as
some of the challenges being faced by these not-for-profit groups as they work
to serve the head and neck community.
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1 | INTRODUCTION
The global COVID-19 pandemic has had a significant
impact on all aspects of society, with a large burden
falling on members of the health care community. With
hospitals focusing on those ill from COVID-19, patients
with cancer have the potential for delay or reduction in
care as clinical resources have been compromised.
Few populations have felt the effects of these changes
more than those being evaluated or treated for head
and neck cancer (HNC) as the multidisciplinary require-
ments for this population includes dental,-
otolaryngology—head and neck surgery, and radiation
and medical oncology, among others. The mucosal
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nature of many of these cancers results in significant con-
cerns about aerosolization of viral particles and the
potential for delays in care. In an effort to minimize
infection transmission and conserve the limited supply of
personal protective equipment (PPE), health systems
have instituted policies that encourage social distancing
such as postponement of elective surgeries and outpatient
clinic visits, elimination of hospital visitors, and rapid
adoption of alternative means of care such as telemedi-
cine and drive-through testing.
Multiple societies and organizations involved in HNC
care across different specialties, including otolaryngology—
head and neck surgery, radiation oncology, dentistry,
speech/swallowing pathology, and medical oncology, have
promptly issued management algorithms to guide clini-
cal care during this pandemic1-3 The shift of focus away
from nonurgent conditions has been instrumental in
creating a united effort to combat infection. However,
there is little precedent for navigating oncologic care
during such times. These abrupt changes in manage-
ment may leave patients with cancer undergoing active
treatment frightened, uneasy, and isolated. Given the
higher rates of emotional distress, cancer and treatment
impact on daily living, and mucosal exposures seen in
patients with HNC, these individuals appear to be par-
ticularly vulnerable to the fear and anxiety produced by
the on-going public health emergency.4
Even in normal circumstances, let alone in this cur-
rent climate, HNC patients often are in need of guidance
to alleviate their concerns and many advocacy organiza-
tions have been proactive in providing support through
various platforms such as news articles, webinars, and
financial assistance. In addition to meeting patients'
needs, advocacy groups also play roles in providing
patient education and raising public awareness, moderat-
ing call lines and chat forums, sustaining research
through public or private funding, and representing the
HNC community on legislative boards. This timely and
important special communication provides an outline of
the issues being faced by patients with HNC and care-
givers during the COVID-19 pandemic, and some of the
programs that have been developed by advocacy organi-
zations to address them. This unprecedented collabora-
tion among a variety of organizations and advocacy
groups also provides critical information on how the cur-
rent crisis has impacted the utilization of these groups
and the unique challenges being faced as they work to
offer needed services to their communities.
To capture up-to-date, relevant information on the
impact of COVID-19 on head and neck advocacy organi-
zations, representatives of six prominent North American
HNC advocacy groups were contacted to ask for partici-
pation by providing their respective groups' experience
during COVID-19. Semi-structured interviews were then
conducted via phone and email communications with all
responding organizations to identify: changes in volume
of people in contact with their organization (including
web site traffic, social media engagement, support phone
line volume, and email communications), changes in
observed patient concerns, changes in HNC advocacy
group programs, and challenges faced by advocacy orga-
nizations during the COVID pandemic. Five out of six
invited organizations participated in interviews. Informa-
tion obtained from these communications is qualitatively
summarized in the discussion below.
2 | PATIENT CONCERNS
Patients with HNC have many concerns surrounding the
impact of COVID-19. These individuals may experience
more psychosocial morbidity than non-HNC patients due
to perceived disfigurement and the inability to speak and
eat properly.5 This may leave these patients even more
vulnerable to the uncertain nature of changing treatment
paradigms and mandates of social isolation. In addition,
given the immunosuppression resulting from treatment
as well as HNC-specific sequelae such as having a trache-
ostomy or a laryngectomy stoma, HNC patients are an at-
risk population for COVID-19 infection. As such, worries
that are natural to arise from the COVID-19 pandemic
may be heightened in this group. These anxieties may
manifest as concerns regarding both the acute risk of
COVID-19 infection as well as its impact on their cancer
treatment. The current environment may make many
patients wary of any health care environment for fear of
infection. This, coupled with the inability to proceed with
care alongside family members, has even led some
patients to avoid treatment altogether of their cancer.6
Additional concerns of HNC patients revolve around
accessibility and/or delay of treatment. Uncertainty
regarding medical, personal, and social issues is already
prevalent in a patient's life with cancer and the current
climate exacerbates these concerns. Management for
HNC now requires reassessment of risk and benefits of
treatment during the COVID-19 era, and alterations from
standard practice, such as foregoing adjuvant chemother-
apy, may occur. A point of concern therefore is how
changes in overall management may affect patient out-
comes. This sentiment was recently reflected in a state-
ment by a HNC patient on the Head and Neck Cancer
Alliance's (HNCA) Inspire patient forum, and is echoed
by many others:
“My fear is that we, patients with cancer, will not get
the best treatments, if any. If all doctors and nurses are
mobilized to help infected people who will treat us?"
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This patient concern is not unfounded. A recent survey
of more than 1200 patients with cancer and survivors by
the American Cancer Society Cancer Action Network
(ACSCAN), found that 27% of patients in active treat-
ment experienced delays secondary to COVID-19 precau-
tions, and 13% of those did not receive any information
on rescheduling of treatment.7 In this same assessment,
over 40% of active treatment patients felt that the
response to COVID-19 would decrease access to care. Pri-
oritization of HNC treatment, although necessary to tri-
age most high-risk cases, may leave certain groups
unattended. Ambassadors to the HNCA, who lead group
discussions with HNC survivors, have noticed that many
patients are worried they are not being considered a pri-
ority anymore. This may include those receiving symp-
tomatic or palliative care, or those with low-risk
pathologies such as low-grade salivary cancers or differ-
entiated thyroid cancers.8 Especially in the survivorship
period, HNC patients may be at higher risk for com-
promised physical and psychosocial well-being9 and may
suffer disproportionately from discontinuation of mainte-
nance oncologic care.
Many support groups also have had to cancel meet-
ings due to the shelter-in-place requirements. This leaves
many patients with limited contact with those having
similar post-treatment issues. These support groups, espe-
cially for laryngectomees, provide important information
on how to cope with a new “normal.” These individuals
often feel isolated due to limited vocalization options
making personal interactions difficult. As a result, alter-
native portals, like videoconferences, have been instru-
mental as they offer a chance to have some safe social
communications.
In addition to concerns regarding treatment and the
associated recovery, those in the post-treatment or survi-
vorship phase may worry about the fear of recurrence, as
in-person follow-up visits usually entailing scoping proce-
dures or surveillance imaging may be indefinitely post-
poned. Head and neck surgeons may suggest visits be
held by way of telemedicine and may order surveillance
imaging if in-person examinations cannot be completed.
However, these virtual visits lack a detailed physical
exam, and patients scheduled for imaging may find these
services inaccessible. In fact, the recent ACSCAN survey
reported 20% of patients whose care has been impacted
by COVID-19 were unable to undergo imaging in the
post-treatment context.7
Another patient concern may be the added logistical
challenges that now accompany their care. HNC patients
have a higher financial burden compared to other can-
cers and often are of lower income and educational
levels, with poorer baseline health status.10 This has been
observed by advocacy groups, as the majority of phone
calls to the HNCA have been regarding financial ability
to afford treatment itself and transportation to medical
facilities. Baddour et al hypothesized that over 60% of
HNC survivors may be impacted by COVID-19's strain on
the economy, especially as it has forced many into tem-
porary unemployment.11 Similarly, the aforementioned
ACSCAN survey also revealed that 38% of respondents
felt significant financial strain during this COVID-19 era,
with 50% of patients with annual income <$30 000
expressing concern regarding how to afford treatment.7
Moreover, although Medicare covers most items for lar-
yngectomees, they do not always provide reasonable
reimbursement to hospitals and clinics for materials such
as in-dwelling speech prostheses. Those impacted
patients therefore have to pay out of pocket for covered
items that some facilities refuse to provide. It is clear that
economic hardships not only affect access to treatment,
but also can significantly impact mental health and
decrease overall quality of life.
The Head and Neck Cancer Living Foundation
(HNCLF) provides financial assistance to low-income
HNC patients for treatment and recovery expenses. Since
COVID-19, this patient population has experienced even
greater barriers to care as social services and discount
providers are less available than ever before. For exam-
ple, HNC patients often require immediate oral health
care before and after treatment. Low-income patients
often depend on local dental partners that offer discounts
or even local dental schools for assistance. Many of these
clinics, dental schools and local dental providers have
closed or significantly reduced their services in response
to COVID-19, leaving these patients with fewer options
for care and greater need for support.
Lastly, the primary advocate of HNC patients, besides
themselves, may be their family members or friends,
serving as caregivers. Unfortunately, social distancing
precautions have limited outside visitors to treatment
facilities at which patients may receive care. Many HNC
patients undergoing treatment or requiring workup will
have to do so by themselves. Often, these individuals also
require transportation support to and from appointments.
Social distancing guidelines have impacted the availabil-
ity of volunteers willing to provide transportation sup-
port, therefore affecting the ability of the patient to access
the care they need. Patients are now challenged with
finding safe transportation and navigating their care
alone. This isolating effect may make coping with cancer
during the COVID-19 era all the more difficult. The exact
impact this has may differ on an individual level and can
also depend on what phase of their cancer journey
patients are in, and future investigation is needed to best
characterize concerns and develop patient-centered strat-
egies to alleviate them.
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3 | ASPECTS OF ADVOCACY
SUPPORT
HNC advocacy groups play a unique role in supporting
patients with cancer at the individual, community, and
national level. From cancer prevention through screening
events to advancement of the field by increasing research
funding, these organizations are instrumental in all
phases of cancer care. Just as our health care system has
adapted to the current COVID-19 climate by shifting
efforts towards urgent medical needs, HNC advocacy
groups have also prioritized providing individual level
support to patients during this crisis. This has included
offering educational resources to keep patients informed
in regards to COVID-19, providing psychosocial support
in the face of uncertainty, and assisting financially with
costs of general living and care.
Professional organizations and HNC advocacy groups
have responded promptly to concerns of patients by pub-
lishing numerous web-based articles, webinars, and
podcasts to accurately inform patients of the impact of
COVID-19. General precautions regarding symptoms of
COVID-19, best practices to reduce exposure and infectiv-
ity, and cancer care in the context of a pandemic have
been the focus of many HNC advocacy groups. For exam-
ple, the Thyroid and Head and Neck Cancer (THANC)
Foundation has released helpful suggestions on how to
handle changes in appointments or surgery as well as
contingency plans in case of possible COVID-19 infec-
tion.12 In addition, this organization has provided thyroid
cancer-specific information, as often the medical man-
agement of thyroid cancer may be impacted by COVID-
19.12 Both the HNCA and the THANC Foundation have
given specific precautions for patients with tracheosto-
mies or laryngectomee patients to reduce the risk of
infection12,13
The HNCA has also worked to recognize and educate
about psychosocial issues of HNC patients during a pan-
demic, especially those with concomitant psychiatric
diagnosis such as major depressive disorder, anxiety dis-
orders, or post-traumatic stress disorder. Highlighting
these issues not only normalizes the psychological dis-
tress patients may face, but also provides succinct, yet
helpful tips to them.
Many advocacy groups are committed to continuing
all aspects of support as COVID-19 allows. Online forums
have provided an avenue for patients to foster virtual
relationships with other survivors. For example, ambas-
sadors on HNCA's Inspire blog have been actively posting
messages of support and ways of coping to aid in elevat-
ing morale. Call lines have been kept open to provide
patient and caregiver guidance during this time of crisis.
Survivor matching programs also pair cancer survivors
with newly diagnosed patients with cancer to foster per-
sonal relationships that provide support and direction.
Interestingly, representatives from Support for People
with Oral and Head and Neck Cancer (SPOHNC) have
noticed patients not only calling in to ask about specific
concerns regarding COVID-19, but also to relay their feel-
ings of isolation, anxiety and stress, placing advocacy
group representatives in a position to help console and
reprieve. This organization has also noticed that relatives
of newly diagnosed patients with cancer are calling in to
“apply” for their loved ones to be matched with a survi-
vor, as concerns about the vulnerability of family mem-
bers with HNC during this period of social isolation are
heightened. In response, SPOHNC has noted that over
100 HNC support groups are now connecting through
video-sharing platforms and Facebook rather than in-per-
son, with similar sessions also being hosted by branches
of the HNCA.
Multiple financial assistance programs are also being
utilized during this time of increased economic distress.
The HNCA has provided gas cards to help patients afford
transportation to and from office visits or treatment.
Industry partners have also collaborated with the HNCA
to provide waivers for drug costs during COVID-19 and
to provide direct patient assistance through HNCA's gas
card program. Plans are underway to release a COVID-
19-related webinar to help navigate HNC patients
through these financially difficult times. The HNCLF
provides financial assistance to low-income HNC patients
nationwide to help with the costs of nutritional supple-
ments, medical supplies not covered by insurance,
copays, transportation, lodging, and dental care. In addi-
tion, CancerCare, a general oncology advocacy group,
has been targeting patients specifically undergoing active
treatment who have been affected by COVID-19 to offset
costs of general household expenses, transportation,
childcare, and medication.14
This wide variety of programs is meant to support
HNC patients and their caregivers not only during treat-
ment but also as they continue into survivorship. Addi-
tional work is underway to formally evaluate the needs
and concerns of those reaching out to these organizations
with the goal of being able to better serve them in the
future.
4 | INCREASED UTILIZATION/
INTERACTION WITH ADVOCACY
GROUPS
As previously mentioned, COVID-19 has led to the can-
cellation of in-office visits, with a shift towards telemedi-
cine encounters. Many ancillary and rehabilitation
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therapy visits, such as speech-language-pathology
appointments, are also being delayed. In addition,
shelter-in-place orders and social distancing precautions
have prevented many HNC patients from attending regu-
larly scheduled support groups. The increased detach-
ment related to social isolation and lack of contact from
regular support groups has led many patients to turn to
HNC advocacy groups as a primary source of information
regarding their concerns on how their care will be
impacted.
This shift in information gathering has been demon-
strated by increases in visits to websites of advocacy
groups and the number of views of relevant web pages.
The THANC Foundation, for example, offers a compre-
hensive HNC guide that touches upon all aspects of
care, from diagnosis to treatment to survivorship (www.
THANCguide.org). From March 28, 2020 to April
26, 2020, they noticed increases in users (71 686 vs
66 472), new users (69 806 vs 64 667), sessions (79 069
vs 74 188), and page views (101 447 vs 96 818) compared
with the month prior. One of their COVID-19-specific
information pages likewise has had 1507 unique visits
in the last month alone. As patients are not able to see
their doctors regularly, they may be turning to online
guides for sources of information.
In addition, there have been an increased number of
phone calls, emails, and messages on social media plat-
forms contacting these organizations. A SPOHNC repre-
sentative has noticed that phone calls are more frequent
and lengthy, increasing from an average of 15-20 to
30-35 minutes (exact data not available). Many patients
are also phoning in outside of regular business hours to
voice their general anxieties and concerns. Similarly, the
UK Macmillan Cancer Support group has noticed an
uptick in volume, with over 30% of incoming calls involv-
ing COVID-19-related concerns.15
Advocacy groups also moderate many web-based
survivor forums on which HNC survivors can relay their
general experiences, questions or comments as well as
engage with other HNC survivors. Examples include the
Inspire platform forum led by the HNCA as well as a
Facebook group led by SPOHNC. Both forums have
seen large increases in activity. In fact, the HNCA
Inspire forum has had a jump in new membership from
30 new users a month, to roughly 55-60 new monthly
users over this past March and April of 2020. Moreover,
COVID-related posts on the HNCA Facebook site were
viewed by twice as many people (average of 1200 per
post-COVID post compared to the pre-COVID average
of 600 per post), with the average COVID-related
postengagement (comments, likes or shares) being
14.5% vs 4% for non-COVID-related posts on this
account. The need for support during treatment has also
increased, with higher utilization of gas cards seen by
the HNCA along with a rise of requests for transporta-
tion and lodging support through the HNCLF.
This increased utilization of advocacy organizations
highlights their important role in the lives of people
affected by HNC. As the pandemic evolves, these groups
will undoubtedly continue to refine their resources in an
effort to best meet the needs of those they serve.
5 | CHALLENGES FACED BY
ADVOCACY ORGANIZATIONS
In addition to the increased need to provide ever-evolving
support to their community, advocacy organizations also
face many direct and indirect challenges to the develop-
ment, implementation and funding of their programs.
One primary service offered by many cancer advocacy
groups is the organization of local awareness events and
support groups. Such meetings in the past have served as
valuable opportunities to increase public knowledge of
HNC and for survivors and caregivers to support and
learn from one another during the challenging time of
cancer treatment and survivorship. As the HNC popula-
tion is a group that is in large part more vulnerable to
respiratory diseases such as COVID-19, increasing care
must be taken when organizing such gatherings. Regular
in-person meetings are no longer appropriate in the cur-
rent climate of social distancing. However, while technol-
ogies like teleconferencing may allow many professions
to continue regular and productive interactions, many
HNC survivors may not have the resources or familiarity
with these platforms to be able to fill this void.
In addition to the disruption of smaller local meet-
ings, larger national programs have also been impacted.
One primary example is the 2020 Oral and Head and
Neck Cancer Awareness Week. This annual event, hosted
by the HNCA, is designed to raise public awareness of
the signs and symptoms of HNC as well as ways of
preventing the disease. Each year, between 200 and
300 screening and awareness events are held worldwide.
Common venues range from community health fairs to
large scale screenings at professional sporting events.
Due to the challenges inherent with social distancing,
screenings this year have been postponed or converted to
media-based awareness campaigns. Consequently, the
ability to garner focused attention and resources for the
cause has been blunted.
An additional prominent program to be impacted is
the inaugural Head and Neck Cancer Survivorship
Symposium that was to be held in Chicago, Illinois, this
July immediately preceding the 2020 International
Meeting of the American Head and Neck Society
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(AHNS). The theme of this meeting was “Survivorship
Through Quality and Innovation,” and such a pairing
was to provide a unique opportunity to join providers
with their patients on a larger scale to not only educate,
but also learn from them and better understand their
needs and priorities. While plans remain underway to
convert aspects of the symposium to an on-line format
and potentially hold an in-person session in conjunction
with the 2021 AHNS meeting, the loss of the current
event is still significant and impactful.
Another consequence of the current crisis has been a
reduction in funding of these not-for-profit organizations.
The HNCLF, for example, was forced to cancel its flag-
ship annual in-person “Masks for Aid” fundraising event,
and convert its development efforts on-line. The
HNCLF's other fundraising initiatives have also been
postponed or rescheduled due to safety concerns related
to COVID-19. Overall, they are expecting a significant
reduction in philanthropic gifts this year. With the
profound overall societal and economic impact of the
pandemic, a sharp decline in general donations to these
advocacy groups is anticipated. Moreover, with shifts
being seen in many aspects of health care, industry sup-
port through educational grants and general sponsorship
may also be reduced.
Lastly, these groups, by their scope and nature have a
limited number of paid and volunteer staff, all of which
are subjected to the same pressures that impact the gen-
eral public at-large such as the risk of infection to them-
selves or their family, transitions to home/e-learning for
education of children, and layoffs of family members
resulting in personal financial strain. However, while all
of these obstacles are significant, by experiencing them,
advocacy organizations are able to better understand and
relate to their communities and develop programs
designed to support them.
6 | CONCLUSIONS
The COVID-19 pandemic is having a profound impact on
HNC patients, creating tremendous anxiety and uncer-
tainty for many individuals undergoing treatment or sur-
veillance for their disease. With the current changes
occurring in health care, the role of HNC advocacy orga-
nizations is becoming increasingly significant, as these
groups are being turned to for information and support.
Despite numerous challenges with program funding and
implementation, these groups continue to find ways to
offer services to their communities. Further work is nec-
essary for these organizations to learn about the evolving
needs of those they serve in order to best refine programs
to support them in the future.
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